a quarter reduction in relatives' refusals.
Medical Research Council's biostatistics unit was through designated regional personnel. They were also intermediary between the statistical centre and inIntroduction tensive care units in the return and validation of audit
In 1987 the Working Party on the Supply of Donor forms, thereby ensuring anonymity of intensive care Organs for Transplantation recommended: "Each units. Three audit periods were scheduled in 1989-Authority should establish an audit in its constituent January to March, April to June, July to Decemberhospitals in order to record all instances ofthe diagnosis and two in 1990. In the first and second audit phases of brain-stem death, the number of requests made, the 30% and 15% of audit forms respectively failed logical number and nature of organ donations and the reasons checks and had to be returned to intensive care units for any shortfall."' As a result the Department of for correction.9 In later periods fewer than 10% of audit MRC Biostatistics Unit, Health initiated a cost efficient, though not compre-forms failed initial validation.
Cambridge CB2 2BW hensive, centralised, confidential audit of all deaths in Sheila M Gore, PHD, senior intensive care units in England (except those for statistician coronary care only and neonatal intensive care) in 1989 Results Deborah J Cable, data and 1990.23 The audit aimed at achieving efficiency, Altogether 12 133 and 11 890 deaths in intensive care mannabelr oln,dt precision of estimation, and reproducibility between units were audited in England in 1989 and 1990 manager~~~years and at gainng insight to regional variation. The respectively out of total numbers of 12600 and 13 000 manager~~~~~~a u d i t cost less than £20 000, enjoyed good collaboration (estimated after correcting for period specific nonCorrespondence to: in the return and validation of audit forms, and yielded compliance or partial compliance). Compliance by Dr Gore. consistent findings in 1989 and 1990 . Wales joined the intensive care units in England was thus 96s3% in the confidential audit in 1990.
first year and 91*5% in the second year. '0 In Wales, BMJ 1992; 304:349-55 Cohen has called for the deaths of patients ventilated where the audit was introduced in 1990 without a three BMJ VOLUME 304 8 FEBRUARY 1992 month initiation period, 682 deaths were audited out of an estimated 800 (compliance 85 3%).
A total of 634 and 568 cadaveric donors of solid organs from intensive care units were audited in England in 1989 and 
Discussion
In England compliance with the confidential audit was 96% in the first year and 91% in the second. Moreover, the audit was estimated to be 84% representative of cadaveric solid organ donation. It was designed to report questions 1 to 14 (fig 1) with adequate precision after three months2; questions 14 to 18 after six months3; regional variation after one year; and, after two years, an assessment of regional consistency between 1989 and 1990 and updating with considerable precision of earlier estimates. These objectives were met through good cooperation from regional liaison officers and intensive care unit staff.
MYTHS
Brain stem death is a possible diagnosis in only 13-6% (between 1700 and 1800 cases) of the estimated 13 000 patients each year who die in intensive care units in England and is confirmed in only 10% of these deaths (between 1200 and 1350 cases a year). These represent half and one third respectively2 of previous estimates and yield far fewer than the projected 1700 kidney donors needed a year in England.' Moreover, the proportion of patients confirmed as brain stem dead who become actual donors (50%) would need to increase substantially to meet even the present need for 1060 kidney donors a year in England.
Intervening between confirmed brain stem death and kidney donation are general medical contraindications to organ donation (in 18% of confirmed brain stem deaths, but subject to regional variation), failure to ask about organ donation (in only 6% of potential donor families, but the second reason (after relatives' refusal) for lost kidneys from brain stem dead potential donors), and relatives' refusal (30% of families refused). As 94% of families of potential donors were asked about organ donation, required request legislation is unnecessary for the United Kingdom. The large proportion of families who refuse consent suggests that we should reappraise opting out schemes, such as in Belgium, and Austria's presumed consent. Those two countries have the highest cadaveric kidney donor rates in Europe (in 1989 Austria had 26 kidney donors per million inhabitants and Belgium 20 per million).'2 In Belgium, where 2% of the adult population has registered objection to organ donation, the philosophy is that opting out shares the onus of decision making between the deceased (in life) and surviving relatives. Does opting out, or presumed consent, lead to lower refusal rates by relatives? A confidential audit ofdeaths in intensive care units in Belgium and Austria would be revealing. How do Belgium and Austria compare with England in numbers of deaths in intensive care units per million population and in mean age at death and cause of death in these units, all of which are subject to regional variation in England? How do Belgian and Austrian intensive care facilities compare with those in England, where the average is 6-1 (SE 0-18) beds, 5*0 (0-17) funded beds, and 4-4 (0 15) staffed beds per unit? MORALS Because ofthe striking regional variation in estimated numbers of deaths in intensive care units per million residents we have introduced two new, apt measures for international comparison of solid organ donation from these units. These are (a) solid organ donors (also corneal donors) per 100 deaths and (b) solid organ donors per 100 confirmed brain stem deaths. In 1989 and 1990 solid organ donor and corneal donor rates in England were 5 0 (95% confidence interval 4 7 to 5 3) and 3 9 (3 7 to 4 2) per 100 intensive care unit deaths and the solid organ donor rate 50 (48 to 52) per 100 confirmed brain stem deaths in these units. Regional variation in donation from intensive care units was dramatic when counted by all deaths in these units (table II; X213= 134 for solid organ donors and 150 for corneal donors in 1989 and 1990 combined) and remained highly significant (p<0-001; X213=38) when counted by confirmed brain stem deaths.
The Thames regions (E, F, G, and H), with a higher than average age at death in intensive care and higher proportions of deaths due to extracranial causes, were in deficit of solid organ donors per 100 intensive care unit deaths (314 audited v 427 expected), as were special health authority T and Mersey region (N), both of which reported high percentages of infant deaths to the confidential audit (28% and 7% v 2% in the rest of England). Wessex and Oxford regions (J and K), with a younger than average age at death in intensive care and lower proportions of deaths due to extracranial causes, reported many more solid organ donors (173) than expected (96-7) by numbers of deaths. The same was true of the Northern region (A) with its 79% of deaths due to extracranial causes and, in 1990, a low incidence of non-performance of tests for brain stem death when brain stem death was a possible diagnosis (12%; 16 cases out of 132 possible brain stem deaths).
Whether brain stem death is a possible diagnosis and whether tests for brain stem death are performed differentiate between the above two measures of solid organ donation from intensive care units. Gentleman et BMJ VOLUME 304 al reported (a) that in 16 of 50 ventilated patients not performance of tests for brain stem death if delays were tested for brain stem death asystole occurred before minimised, and (b) a quarter reduction in relatives' testing was done and (b) that asystole may occur refusals, as occurred in October and November 1989 because of delay in initiating tests or because an during sustained publicity about the need for transinterval of 12-24 hours is left between the first and plantation. Instead of 1768 possible and 1300 confirmed second sets of tests.7 The British criteria do not specify brain stem deaths in intensive care units there would be a long interval before repeating the tests,'3" 14 and delay 100 additional confirmed brain stem deaths. Instead of increases the likelihood of hypotension. In future 696 offered donors from 1300 confirmed brain stem audits reasons for non-performance of tests for brain deaths there would be an additional 72 offered donors stem death should be sought. The Glasgow data if refusals were reduced by a quarter. From the 100 suggest that non-performance of tests for brain stem additional confirmed brain stem deaths there would be death could be reduced by up to one third without an additional 54 offered donors-or 59 if the consent delays. The Northern region halved its incidence of rate increased from 70% to 77 5%. Hence these two non-performance of tests for brain stem death between changes could increase the number of cadaveric kidney 1989 and 1990 , and the incidence of non-performance donors by nearly a fifth. Action on general medical in the North East Thames region has been consistently contraindications to organ donation could diminish lower by a quarter, at 18%, than for England as a another major barrier: specialist review of over 400 whole.
listed general medical contraindications in the conRegional variation in whether brain stem death was a fidential audit will be reported subsequently. 
